Table 7.
Test point | Treatment Phase 1 | Treatment Phase 2 |
---|---|---|
Pretreatment | 0 | 0 |
36 exposures in Treatment 1 | 1 | 0 |
Immediate post–Treatment 1 | 2 | 0 |
2-week post–Treatment 1 | 2 | 0 |
36 exposures in Treatment 2 | 2 | 1 |
Immediate post–Treatment 2 | 2 | 2 |
2-week post–Treatment 2 | 2 | 2 |